Rapamycin together with TGF-β1, IL-2 and IL-15 induces the generation of functional regulatory γδT cells from human peripheral blood mononuclear cells

Journal of Immunological Methods

Volumn 402, Issue 1-2, 2014, Pages 82-87

  Gu, Yanjun ^a   Hu, Yongxian ^a   Hu, Kaimin ^a   Liao, Weichao ^a   Zheng, Feilin ^a   Yu, Xiaohong ^a   Huang, He ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Foxp3; Immunosuppression; Induction; Rapamycin; Treg

Indexed keywords

BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; FOXP3; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INDUCTION; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; ΓΔTREG;

FOXP3; IMMUNOSUPPRESSION; INDUCTION; RAPAMYCIN; ΓΔTREG;

BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84888153733     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.11.009     Document Type: Article

References (19)

1. Bansal R.R., Mackay C.R., Moser B., Eberl M. IL-21 enhances the potential of human γδ T cells to provide B-cell help. Eur. J. Immunol. 2012, 42(1):110. (Jan).
2. Bonneville M., O'Brien R.L., Born W.K. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 2010, 10(7):467. (Jul).
3. Busse M., Krech M., Meyer-Bahlburg A., et al. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance. J. Immunol. 2012, 189(4):1975. (Aug 15).
4. Casetti R., Agrati C., Wallace M., et al. Cutting edge: TGF-beta1 and IL-15 Induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulation. J. Immunol. 2009, 183(6):3574. (Sep 15).
5. Hu Y., Cui Q., Gu Y., et al. Decitabine facilitates the generation and immunosuppressive function of regulatory γδT cells derived from human peripheral blood mononuclear cells. Leukemia 2013 Jul, 27(7):1580-1585.
6. Johnston L.J., Brown J., Shizuru J.A., et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 2005, 11(1):47.
7. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 2003, 4(4):337. (Apr).
8. Li X., Kang N., Zhang X., et al. Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J. Immunol. 2011, 186(12):6693. (Jun 15).
9. Märten A., Lilienfeld-Toal M., Büchler M.W., Schmidt J. Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cells. J. Immunother. 2007, 30(4):370. (May-Jun).
10. Moreira-Teixeira L., Resende M., Devergne O., et al. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. J. Immunol. 2012, 188(2):624. (Jan 15).
11. Morita C.T., Beckman E.M., Bukowski J.F., et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995, 3(4):495. (Oct).
12. Seissler N., Schmitt E., Hug F., et al. Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patients. Transpl. Immunol. 2012, 27(4):157. (Dec).
13. Song K., Wang H., Krebs T.L., Danielpour D. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J. 2006, 25(1):58. (Jan 11).
14. Tone Y., Furuuchi K., Kojima Y., et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 2008, 9(2):194. (Feb).
15. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., et al. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004, 50(9):2775. (Sep).
16. Ye J., Ma C., Hsueh E.C., et al. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence. J. Immunol. 2013, 190(5):2403. (Mar 1).
17. Yu N., Li X., Song W., et al. CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood. Inflammation 2012, 35(6):1773. (Dec).
18. Zeng H., Yang K., Cloer C., et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 2013, 499(7459):485-490. (Jul 25).
19. Zhou J., Appleton S.E., Stadnyk A., Lee T.D., Nashan B.A. CD8+ gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen. Transpl. Int. 2008, 21:679.